These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed. Pittman PR, Cavicchia MA, Kingsbury JL, Johnson NA, Barrera-Oro JG, Schmader T, Korman L, Quinn X, Ranadive M. Vaccine; 2014 Sep 03; 32(39):5131-9. PubMed ID: 24837771 [Abstract] [Full Text] [Related]
16. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization. Dumas EK, Nguyen ML, Cox PM, Rodgers H, Peterson JL, James JA, Farris AD. Vaccine; 2013 Apr 03; 31(14):1856-63. PubMed ID: 23415781 [Abstract] [Full Text] [Related]
17. Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infection. Merkel TJ, Perera PY, Lee GM, Verma A, Hiroi T, Yokote H, Waldmann TA, Perera LP. Hum Vaccin Immunother; 2013 Sep 03; 9(9):1841-8. PubMed ID: 23787486 [Abstract] [Full Text] [Related]
18. Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax. Semenova VA, Schmidt DS, Taylor TH, Li H, Steward-Clark E, Soroka SD, Ballard MM, Quinn CP. Vaccine; 2007 Feb 26; 25(10):1780-8. PubMed ID: 17229495 [Abstract] [Full Text] [Related]
20. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model. Suryanarayana N, Verma M, Thavachelvam K, Saxena N, Mankere B, Tuteja U, Hmuaka V. Appl Microbiol Biotechnol; 2016 Oct 26; 100(19):8439-51. PubMed ID: 27364624 [Abstract] [Full Text] [Related] Page: [Next] [New Search]